Leaders with Lacqua: Vasant Narasimhan, Novartis CEO

Leaders with Lacqua: Vasant Narasimhan, Novartis CEO

Vasant Narasimhan, the CEO of Novartis who earns Rs 20 lakh per day? #shorts @NeuacticПодробнее

Vasant Narasimhan, the CEO of Novartis who earns Rs 20 lakh per day? #shorts @Neuactic

Novartis CEO Vas Narasimhan on the latest research on a breast cancer drugПодробнее

Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug

Novartis CEO Vas Narasimhan on The David Rubenstein ShowПодробнее

Novartis CEO Vas Narasimhan on The David Rubenstein Show

Vasant Narasimhan Novartis CEO On Transforming Pharma IndustryПодробнее

Vasant Narasimhan Novartis CEO On Transforming Pharma Industry

Novartis CEO Vas Narasimhan on Covid-19 AntibodiesПодробнее

Novartis CEO Vas Narasimhan on Covid-19 Antibodies

Novartis “on track” to bring one of the most expensive drugs to EuropeПодробнее

Novartis “on track” to bring one of the most expensive drugs to Europe

Meet our people: Vas NarasimhanПодробнее

Meet our people: Vas Narasimhan

Leaders Never Go Alone: Vas Narasimhan in conversation with Jennifer Garvey BergerПодробнее

Leaders Never Go Alone: Vas Narasimhan in conversation with Jennifer Garvey Berger

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” companyПодробнее

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company

Novartis CEO Narasimhan on Growth Prospects, Pandemic DisruptionПодробнее

Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption

Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19Подробнее

Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19

Watch CNBC's full interview with Novartis CEO Vas NarasimhanПодробнее

Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Novartis CEO on new cancer therapy programsПодробнее

Novartis CEO on new cancer therapy programs

Novartis expects 'strong momentum' going into second half, says CEO Vasant NarasimhanПодробнее

Novartis expects 'strong momentum' going into second half, says CEO Vasant Narasimhan

2018 WMIF | 1:1 Fireside Chat: Vasant Narasimhan, MD, CEO, NovartisПодробнее

2018 WMIF | 1:1 Fireside Chat: Vasant Narasimhan, MD, CEO, Novartis

The Future of Human Health: Panel discussionПодробнее

The Future of Human Health: Panel discussion

Novartis not joining the 'frenzy' of weight loss drugs, CEO saysПодробнее

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

Roche CEO Severin Schwan on Leaders With LacquaПодробнее

Roche CEO Severin Schwan on Leaders With Lacqua